Walsh NP, Gleeson M, Shephard RJ, Gleeson M, Woods JA, Bishop NC, et al. Position statement. Part one: immune function and exercise. Exerc Immunol Rev. 2011;17:6–63.
Kruijsen-Jaarsma M, Révész D, Bierings MB, Buffart LM, Takken T. Effects of exercise on immune function in patients with cancer: a systematic review. Exerc Immunol Rev. 2013;19:120–43.
Timmons BW, Cieslak T. Human natural killer cell subsets and acute exercise: a brief review. Exerc Immunol Rev. 2008;14:8–23.
Rumpf C, Proschinger S, Schenk A, Bloch W, Lampit A, Javelle F, et al. The effect of acute physical exercise on NK-cell cytolytic activity: a systematic review and meta-analysis. Sport Med. 2021;51:519–30. https://doi.org/10.1007/s40279-020-01402-9.
Rincón HG, Solomon GF, Benton D, Rubenstein LZ. Exercise in frail elderly men decreases natural killer cell activity. Aging Clin Exp Res. 1996;8:109–12.
Suzui M, Kawai T, Kimura H, Takeda K, Yagita H, Okumura K, et al. Natural killer cell lytic activity and CD56(dim) and CD56(bright) cell distributions during and after intensive training. J Appl Physiol. 2004;96:2167–73.
MacNeil B, Hoffman-Goetz L. Chronic exercise enhances in vivo and in vitro cytotoxic mechanisms of natural immunity in mice. J Appl Physiol. 1993;74:388–95.
Estruel-Amades S, Camps-Bossacoma M, Massot-Cladera M, Pérez-Cano FJ, Castell M. Alterations in the innate immune system due to exhausting exercise in intensively trained rats. Sci Rep. 2020;10:967.
Moro-García MA, Fernández-García B, Echeverría A, Rodríguez-Alonso M, Suárez-García FM, Solano-Jaurrieta JJ, et al. Frequent participation in high volume exercise throughout life is associated with a more differentiated adaptive immune response. Brain Behav Immun. 2014;39:61–74.
Nieman DC, Buckley KS, Henson DA, Warren BJ, Suttles J, Ahle JC, et al. Immune function in marathon runners versus sedentary controls. Med Sci Sports Exerc. 1995;27:986–92.
Pedersen B, Tvede N, Christensen L, Klarlund K, Kragbak S, Halkjr-Kristensen J. Natural killer cell activity in peripheral blood of highly trained and untrained persons. Int J Sports Med. 1989;10:129–31.
Nieman DC, Nehlsen-Cannarella SL, Fagoaga OR, Henson DA, Shannon M, Hjertman JM, et al. Immune function in female elite rowers and non-athletes. Br J Sports Med. 2000;34:181–7.
Nieman DC, Henson DA, Gusewitch G, Warren BJ, Dotson RC, Butterworth DE, et al. Physical activity and immune function in elderly women. Med Sci Sports Exerc. 1993;25:823–31.
Di Vito C, Mikulak J, Zaghi E, Pesce S, Marcenaro E, Mavilio D. NK cells to cure cancer. Semin Immunol. 2019;41:101272. https://doi.org/10.1016/j.smim.2019.03.004.
Huntington ND, Cursons J, Rautela J. The cancer–natural killer cell immunity cycle. Nat Rev Cancer. 2020;20:437–54. https://doi.org/10.1038/s41568-020-0272-z.
López-Soto A, Gonzalez S, Smyth MJ, Galluzzi L. Control of metastasis by NK cells. Cancer Cell. 2017;32:135–54.
Larsen S, Gao Y, Basse P. NK cells in the tumor microenvironment. Crit Rev Oncol. 2014;19:91–105.
Imai K, Matsuyama S, Miyake S, Suga K, Nakachi K. Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population. Lancet. 2000;356:1795–9.
Tang YP, Xie MZ, Li KZ, Li JL, Cai ZM, Hu BL. Prognostic value of peripheral blood natural killer cells in colorectal cancer. BMC Gastroenterol. 2020;20:1–8.
Cursons J, Souza-Fonseca-Guimaraes F, Foroutan M, Anderson A, Hollande F, Hediyeh-Zadeh S, et al. A gene signature predicting natural killer cell infiltration and improved survival in melanoma patients. Cancer Immunol Res. 2019;7:1162–74.
Li B, Jiang Y, Li G, Fisher GA, Li R. Natural killer cell and stroma abundance are independently prognostic and predict gastric cancer chemotherapy benefit. JCI Insight. 2020. https://doi.org/10.1172/jci.insight.136570.
Lee H, Quek C, Silva I, Tasker A, Batten M, Rizos H, et al. Integrated molecular and immunophenotypic analysis of NK cells in anti-PD-1 treated metastatic melanoma patients. Oncoimmunology. 2019;8:1–10. https://doi.org/10.1080/2162402X.2018.1537581.
Pedersen L, Idorn M, Olofsson GH, Lauenborg B, Nookaew I, Hansen RH, et al. Voluntary running suppresses tumor growth through epinephrine- and IL-6-dependent NK cell mobilization and redistribution. Cell Metab. 2016;23:554–62.
Evans ES, Hackney AC, McMurray RG, Randell SH, Muss HB, Deal AM, et al. Impact of acute intermittent exercise on natural killer cells in breast cancer survivors. Integr Cancer Ther. 2015;14:436–45.
Zimmer P, Bloch W, Schenk A, Zopf EM, Hildebrandt U, Streckmann F, et al. Exercise-induced natural killer cell activation is driven by epigenetic modifications. Int J Sports Med. 2015;36:510–5.
Hanson ED, Sakkal S, Que S, Cho E, Spielmann G, Kadife E, et al. Natural killer cell mobilization and egress following acute exercise in men with prostate cancer. Exp Physiol. 2020;105:1524–39.
Zimmer P, Schenk A, Kieven M, Holthaus M, Lehmann J, Lövenich L, et al. Exercise induced alterations in NK-cell cytotoxicity—methodological issues and future perspectives. Exerc Immunol Rev. 2017;23:66–81.
Hagstrom AD, Marshall PWM, Lonsdale C, Papalia S, Cheema BS, Toben C, et al. The effect of resistance training on markers of immune function and inflammation in previously sedentary women recovering from breast cancer: a randomized controlled trial. Breast Cancer Res Treat. 2016;155:471–82.
Fairey AS, Courneya KS, Field CJ, Bell GJ, Jones LW, Mackey JR. Randomized controlled trial of exercise and blood immune function in postmenopausal breast cancer survivors. J Appl Physiol. 2005;98:1534–40.
Na Y-M, Kim M-Y, Kim Y-K, Ha Y-R, Yoon DS. Exercise therapy effect on natural killer cell cytotoxic activity in stomach cancer patients after curative surgery. Arch Phys Med Rehabil. 2000;81:777–9.
Chamorro-Viña C, Valentín J, Fernández L, González-Vicent M, Pérez-Ruiz M, Lucía A, et al. Influence of a moderate-intensity exercise program on early NK cell immune recovery in pediatric patients after reduced-intensity hematopoietic stem cell transplantation. Integr Cancer Ther. 2017;16:464–72.
Nieman DC, Cook VD, Henson DA, Suttles J, Rejeski WJ, Ribisl PM, et al. Moderate exercise training and natural killer cell cytotoxic activity in breast cancer patients. Int J Sports Med. 1995;16:334–7.
Fiuza-Luces C, Padilla JR, Valentín J, Santana-Sosa E, Santos-Lozano A, Sanchis-Gomar F, et al. Effects of exercise on the immune function of pediatric patients with solid tumors: insights from the PAPEC randomized trial. Am J Phys Med Rehabil. 2017;96:831–7.
Khosravi N, Stoner L, Farajivafa V, Hanson ED. Exercise training, circulating cytokine levels and immune function in cancer survivors: a meta-analysis. Brain Behav Immun. 2019;81:92–104. https://doi.org/10.1016/j.bbi.2019.08.187.
Ligibel JA, Dillon D, Giobbie-Hurder A, McTiernan A, Frank E, Cornwell M, et al. Impact of a pre-operative exercise intervention on breast cancer proliferation and gene expression: results from the pre-operative health and body (PreHAB) study. Clin Cancer Res. 2019;25:5398–406.
Mohamady TM, Borhan WH, Abdallah W, AbdelGhani S. Effect of selected exercise program on natural killer cytotoxic cells activity of post-mastectomy patients. Beni-Suef Univ J Basic Appl Sci. 2013;2:114–9. https://doi.org/10.1016/j.bjbas.2013.03.003.
Sagarra-Romero L, Ruidiaz M, Morales SC, Antón-Solanas I, Antón AM. Influence of an exercise program on blood immune function in women with breast cancer. Med Dello Sport. 2018;71:604–16.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA statement: an updated guideline for reporting systematic reviews. BMJ. 2020;2021:372.
Verhagen A, de Vet H, de Bie R, Kessels A, Boers M, Bouter L, et al. The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol. 1998;51:1235–41.
Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M. Cochrane handbook for systematic reviews of interventions version 6.0 [Internet]. Cochrane; 2019. Available from: www.training.cochrane.org/handbook.
Liu J, Chen P, Wang R, Yuan Y, Wang X, Li C. Effect of Tai Chi on mononuclear cell functions in patients with non-small cell lung cancer. BMC Complement Altern Med. 2015;15:1–8.
Kaushik D, Shah PK, Mukherjee N, Ji N, Dursun F, Kumar AP, et al. Effects of yoga in men with prostate cancer on quality of life and immune response: a pilot randomized controlled trial. Prostate Cancer Prostatic Dis. 2021. https://doi.org/10.1038/s41391-021-00470-w.
Toffoli EC, Sweegers MG, Bontkes HJ, Altenburg TM, Verheul HMW, van der Vliet HJ, et al. Effects of physical exercise on natural killer cell activity during (neo)adjuvant chemotherapy: a randomized pilot study. Physiol Rep. 2021;9:1–9.
Glass OK, Inman BA, Broadwater G, Courneya KS, Mackey JR, Goruk S, et al. Effect of aerobic training on the host systemic milieu in patients with solid tumours: an exploratory correlative study. Br J Cancer. 2015;112:825–31. https://doi.org/10.1038/bjc.2014.662.
Schmidt T, Jonat W, Wesch D, Oberg HH, Adam-Klages S, Keller L, et al. Influence of physical activity on the immune system in breast cancer patients during chemotherapy. J Cancer Res Clin Oncol. 2018;144:579–86. https://doi.org/10.1007/s00432-017-2573-5.
Graff RM, Kunz HE, Agha NH, Baker FL, Laughlin M, Bigley AB, et al. β2-Adrenergic receptor signaling mediates the preferential mobilization of differentiated subsets of CD8+ T-cells, NK-cells and non-classical monocytes in response to acute exercise in humans. Brain Behav Immun. 2018;74:143–53. https://doi.org/10.1016/j.bbi.2018.08.017.
Bay ML, Heywood S, Wedell-Neergaard AS, Schauer T, Lehrskov LL, Christensen RH, et al. Human immune cell mobilization during exercise: effect of IL-6 receptor blockade. Exp Physiol. 2020;105:1–13.
Idorn M, Hojman P. Exercise-dependent regulation of NK cells in cancer protection. Trends Mol Med. 2016;22:565–77. https://doi.org/10.1016/j.molmed.2016.05.007.
Ruiz-Casado A, Martín-Ruiz A, Pérez LM, Provencio M, Fiuza-Luces C, Lucia A. Exercise and the hallmarks of cancer. Trends Cancer. 2017;3:423–41. https://doi.org/10.1016/j.trecan.2017.04.007.
Dias RG, Silva MSM, Duarte NE, Bolani W, Alves CR, Junior JRL, et al. PBMCs express a transcriptome signature predictor of oxygen uptake responsiveness to endurance exercise training in men. Physiol Genom. 2015;47:13–23.
Liu D, Wang R, Grant AR, Zhang J, Gordon PM, Wei Y, et al. Immune adaptation to chronic intense exercise training: new microarray evidence. BMC Genom. 2017;18:29.
Pal A, Zimmer P, Schmidt ME, Hummel M, Ulrich CM, Wiskemann J, et al. No evidence for effect of exercise on transcriptome of NK cells in breast cancer patients undergoing adjuvant therapy: results from a pilot study. Front Physiol. 2019;10:959.
Llavero F, Alejo L, FIuza-Luces C, López Soto A, Valenzuela P, Castillo-García A, et al. Exercise training effects on natural killer cells: a preliminary proteomics and systems biology approach. Exerc Immunol Rev. 2020;In press.
Mace EM. Phosphoinositide-3-kinase signaling in human natural killer cells: new insights from primary immunodeficiency. Front Immunol. 2018;9:7–10.
Takahashi N, van Kilsdonk JWJ, Ostendorf B, Smeets R, Bruggeman SWM, Alonso A, et al. Tumor marker nucleoporin 88 kDa regulates nucleocytoplasmic transport of NF-kappaB. Biochem Biophys Res Commun. 2008;374:424–30.
Coletta AM, Agha NH, Baker FL, Niemiro GM, Mylabathula PL. The impact of high—intensity interval exercise training on NK—cell function and circulating myokines for breast cancer prevention among women at high risk for breast cancer. Breast Cancer Res Treat. 2021. https://doi.org/10.1007/s10549-021-06111-z.
Naujoks W, Quandt D, Hauffe A, Kielstein H, Bähr I, Spielmann J. Characterization of surface receptor expression and cytotoxicity of human NK cells and NK cell subsets in overweight and obese humans. Front Immunol. 2020;11:1–19.
Consoli U, El-Tounsi I, Sandoval A, Snell V, Kleine HD, Brown W, et al. Differential induction of apoptosis by fludarabine monophosphate in leukemic B and normal T cells in chronic lymphocytic leukemia. Blood. 1998;91:1742–8.
Sewell HF, Halbert CF, Robins RA, Galvin A, Chan S, Blamey RW. Chemotherapy-induced differential changes in lymphocyte subsets and natural-killer-cell function in patients with advanced breast cancer. Int J Cancer. 1993;55:735–8.
Tsavaris N, Kosmas C, Vadiaka M, Kanelopoulos P, Boulamatsis D. Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes. Br J Cancer. 2002;87:21–7.
Bauernhofer T, Kuss I, Henderson B, Baum AS, Whiteside TL. Preferential apoptosis of CD56dim natural killer cell subset in patients with cancer. Eur J Immunol. 2003;33:119–24.
Stewart L, Moher D, Shekelle P. Why prospective registration of systematic reviews makes sense. Syst Rev. 2012;1:7–10.